ANNALS OF THE RHEUMATIC DISEASES, cilt.77, ss.1710-1719, 2018 (SCI İndekslerine Giren Dergi)
Objectives To evaluate the long-term efficacy and safety of canakinumab in patients with active systemic juvenile idiopathic arthritis (JIA).